medigraphic.com
ISSN 1810-2352 (Print)

2020, Number 3

<< Back Next >>

Rev Cub Med Int Emerg 2020; 19 (3)

Neurointensive management of aneurismal subarachnoid hemorrhage

Galofre-Martínez MC, Ordosgoitia-Morales J, Ripoll-Zapata V, Morales-Núñez MA, Corrales-Santander HR, Moscote-Salazar LR

Language: Spanish
References: 31
Page: 1-23
PDF size: 262.98 Kb.


ABSTRACT

Introduction: Subarachnoid hemorrhage is a disease with high morbidity and mortality rates. The most common cause for this disease is brain trauma, followed by aneurysmal rupture.
Objective: To describe the clinical bases of neurointensive management of subarachnoid hemorrhage from its pathophysiology to the focus on it in the intensive care unit.
Evidence acquisition: We carried out a review of the literature published until July 2018, which included original articles, review articles, systematic reviews, meta-analyses, and clinical trials. The databases used were Pubmed, EBSCO host, Science direct, Clinical Key, and SCOPUS. We took into account articles in English and in Spanish published in the last five years and about the generalities of subarachnoid hemorrhage and neurointensive management in a population older than 18 years. Wo chose 31 articles.
Results: A monograph was written about the basic pathophysiological concepts of aneurysmal subarachnoid hemorrhage, its clinical presentation, diagnosis, complications, and the clinical management of the disease.
Conclusions: Management of aneurysmal subarachnoid hemorrhage in the intensive care unit focuses mainly on the prevention of complications associated with the disease, to improve the clinical prognosis in patients. Basically, continuous vital sign monitoring and brain monitoring should be carried out, and analgesic and antiemetic drugs should be administered, to achieve complete stabilization of the patient.


REFERENCES

  1. Dority JS, Oldham JS. Subarachnoid Hemorrhage An Update. Anesthesiology Clinics. 2016;(3):577-600. Doi: 10.1016/j.anclin.2016.04.009

  2. Abraham MK, Chang WW. Subarachnoid Hemorrhage. Emerg Med Clin North Am. 2016;34(4):901‐16. Doi:10.1016/j.emc.2016.06.011

  3. Raya AK, Diringer MN. Treatment of Subarachnoid Hemorrhage. Crit Care Clin. 2014;30(4):719-33. Doi: 10.1016/j.ccc.2014.06.004

  4. Hughes JD, Bond KM, Mekary RA, Dewan MC, Rattani A, Baticulon R, et al. Estimating the Global Incidence of Aneurysmal Subarachnoid Hemorrhage: A Systematic Review for Central Nervous System Vascular Lesions and Meta-Analysis of Ruptured Aneurysms. World Neurosurg. 2018;115:430‐47.e7. Doi: 10.1016/j.wneu.2018.03.220

  5. Long B, Koyfman A, Runyon MS. Subarachnoid Hemorrhage: Updates in Diagnosis and Management. Emerg Med Clin North Am. 2017;35(4):803-24. Doi: 10.1016/j.emc.2017.07.001

  6. Mortimer AM, Bradley MD, Stoodley NG, Renowden SA. Thunderclap headache: diagnostic considerations and neuroimaging features. Clin Radiol. 2013;68(3):101‐13. Doi: 10.1016/j.crad.2012.08.032

  7. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RH, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40(3):994-1025. Doi: 10.1161/STROKEAHA.108.191395

  8. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg. 2000;93(3):379‐87. Doi: 10.3171/jns.2000.93.3.0379

  9. Brown RD Jr, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol. 2014;13(4):393‐404. Doi: 10.1016/S1474-4422(14)70015-8

  10. Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389(10069):655-66. Doi: 10.1016/S0140-6736(16)30668-7

  11. Etminan N, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage. Handb Clin Neurol. 2017;140:195‐228. Doi:10.1016/B978-0-444-63600-3.00012-X

  12. Diringer MN, Zazulia AR. Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit. Semin Respir Crit Care Med. 2017;38(6):760‐67. Doi:10.1055/s-0037-1607990

  13. Al-Mufti F, Amuluru K, Smith B, Damodara M, El-Ghanem M, Singh IP, et al. Emerging Markers of Early Brain Injury and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2017;107:148‐59. Doi: 10.1016/j.wneu.2017.07.114

  14. Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res. 2013;4(4):432‐46. Doi:10.1007/s12975-013-0257-2

  15. Sabri M, Lass E, Macdonald RL. Early brain injury: a common mechanism in subarachnoid hemorrhage and global cerebral ischemia. Stroke Res Treat. 2013;2013:394036. Doi:10.1155/2013/394036

  16. Bowles E. Cerebral aneurysm and aneurysmal subarachnoid haemorrhage. Nursing standard. 2014;28(34):52-9. DOI: 10.7748/ns2014.04.28.34.52.e8694

  17. Vivancos J, Gilo F, Frutos R, Maestre J, García-Pastor A, Quintana F, et al. Guía de actuación clínica en la hemorragia subaracnoidea. Sistemática diagnóstica y tratamiento. Neurología. 2012;29(6):353-370. Doi: 10.1016/j.nrl.2012.07.009

  18. De Oliveira Manoel AL, Turkel-Parrella D, Duggal A, Murphy A, McCredie V, Marotta TR. Managing aneurysmal subarachnoid hemorrhage: It takes a team. Cleve Clin J Med. 2015;82(3):177‐92. Doi:10.3949/ccjm.82a.14021

  19. Green DM, Burns JD, DeFusco CM. ICU management of aneurysmal subarachnoid hemorrhage. J Intensive Care Med. 2013;28(6):341‐54. Doi:10.1177/0885066611434100

  20. Perry JJ, Stiell IG, Sivilotti MLA, Bullard MJ, Hohl CM, Sutherland J, et al. Clinical Decision Rules to Rule Out Subarachnoid Hemorrhage for Acute Headache. JAMA. 2013;310(12):1248-55. Doi:10.1001/jama.2013.278018

  21. Rabinstein AA, Lanzino G, Wijdicks EF. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2010;9(5):504-19. Doi: 10.1016/S1474-4422(10)70087-9

  22. Connolly Jr ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage. Stroke. 2012;43:1711-37. Doi: 10.1161/STR.0b013e3182587839.

  23. Baggott C, Aagaard B. Cerebral vasospasm. Neurosurg Clin N Am. 2014;25:497-528. Doi: 10.1016/j.nec.2014.04.008.

  24. Lin BF, Kuo CY, Wu ZF. Review of aneurysmal subarachnoid hemorrhage-focus on treatment, anesthesia, cerebral vasospasm prophylaxis, and therapy. Acta Anaesthesiol Taiwan. 2014;52(2):77‐84. Doi: 10.1016/j.aat.2014.04.005

  25. De Oliveira Manoel AL, Jaja BN, Germans MR, Yan H, Qian W, Kouzmina E, et al. The VASOGRADE: A Simple Grading Scale for Prediction of Delayed Cerebral Ischemia after Subarachnoid Hemorrhage. Stroke. 2015;46(7):1826-31. Doi: 10.1161/STROKEAHA.115.008728S

  26. Souter MJ. Critical care of subarachnoid haemorrhage. J Neuroanesthesiology Crit Care. 2017;4:S76-80. Doi: 10.4103/jnacc-jnacc-75.16

  27. Datar S, Rabinstein AA. Postinterventional critical care management of aneurysmal subarachnoid hemorrhage. Curr Opin Crit Care. 2017;23(2):87-93. Doi: 10.1097/MCC.0000000000000391.

  28. Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011 Sep;15(2):211-40. Doi: 10.1007/s12028-011-9605-9.

  29. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med. 2008 Jul;36(7):2070-5. Doi: 10.1097/CCM.0b013e31817c1095.

  30. Kapadia A, Schweizer TA, Spears J, Cusimano M, Macdonald RL. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: diagnosis, pathophysiology, clinical characteristics, and long-term outcome. World Neurosurg. 2014 Dec;82(6):1131-43. Doi: 10.1016/S1474-4422(14)70084-5

  31. Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol. 2014 Jul;13(7):666-75. Doi: 10.1016/j.wneu.2014.07.006




2020     |     www.medigraphic.com